PhaseBio Pharmaceuticals (PHAS) null Earnings

11AugConfirmed
Aug 19
Nov 19
May 20
Aug 20
-0.98
-0.76
-0.54
-0.32

Details

Expected EPS
-0.52
Actual EPS
-0.98
Surprise EPS
-0.46
Surprise Percent
+88.46%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -0.98 per share for .

0 Comments

Share your thoughts